JK

Julia Kaufman

Investment Director at Boehringer Ingelheim

United States

Overview

Work Experience

BI

Boehringer Ingelheim

  • Investment Director, Boehringer Ingelheim Venture Fund USA

    2022 - Current

  • Principal Scientist, Immunology & Respiratory Disease Research

    2019 - 2022

  • Senior Scientist, Immunology & Respiratory Disease Research

    2014 - 2019

RT

Rgenta Therapeutics Inc.

  • Member Board of Directors

    2023

YA

Yoh, A Day & Zimmermann Company

  • Scientist IV

    2014 - 2014

    Contractor providing support to Boehringer Ingelheim.

HH

Howard Hughes Medical Institute at the Rockefeller University

  • Research Specialist II

    2002 - 2013

    • Immunologist investigating the use of autologous dendritic cells and apoptotic tumor cells as an immunotherapy for glioblastoma and prostate cancer. • Responsible for the development of immunological assays, troubleshooting and SOP development and writing. • Responsible for vaccine manufacturing under FDA’s cGMP regulations, including clean room operation, maintenance, QA and QC. • Established monthly self-audits to ensure that our manufacturing, testing and release processes were kept to the highest standard. • Tracking of project progress, reporting to Dr. Darnell and providing written and oral updates for group/lab meetings and funding agencies. • Oversight of contracts with outside vendors and for sourcing new lab equipment purchases. • Interview, train and supervise technicians, helping to build our quality team. • Directly supervised clinical trial team to ensure project goals are met and ensure proper training in policies and procedures.

Albany Medical College

  • Technician

    1995 - 1996

Education

Relevant Websites